Aethlon Medical, Inc. (AEMD)

Aethlon Medical Statistics

Total Valuation

Aethlon Medical has a market cap or net worth of $5.14 million. The enterprise value is $1.04 million.

Market Cap	5.14M
Enterprise Value	1.04M

Important Dates

The next estimated earnings date is Thursday, June 26, 2025, after market close.

Earnings Date	Jun 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Aethlon Medical has 2.58 million shares outstanding. The number of shares has increased by 291.02% in one year.

Current Share Class	2.58M
Shares Outstanding	2.58M
Shares Change (YoY)	+291.02%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.74%
Owned by Institutions (%)	3.52%
Float	2.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.80
P/TBV Ratio	1.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.80, with a Debt / Equity ratio of 0.17.

Current Ratio	2.80
Quick Ratio	2.72
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -160.04% and return on invested capital (ROIC) is -89.86%.

Return on Equity (ROE)	-160.04%
Return on Assets (ROA)	-72.47%
Return on Invested Capital (ROIC)	-89.86%
Return on Capital Employed (ROCE)	-206.96%
Revenue Per Employee	n/a
Profits Per Employee	-$682,758
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.54% in the last 52 weeks. The beta is 1.88, so Aethlon Medical's price volatility has been higher than the market average.

Beta (5Y)	1.88
52-Week Price Change	-57.54%
50-Day Moving Average	2.95
200-Day Moving Average	3.65
Relative Strength Index (RSI)	22.43
Average Volume (20 Days)	39,220

Short Selling Information

The latest short interest is 86,349, so 3.34% of the outstanding shares have been sold short.

Short Interest	86,349
Short Previous Month	102,085
Short % of Shares Out	3.34%
Short % of Float	3.87%
Short Ratio (days to cover)	0.59

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.83M
Pretax Income	-12.21M
Net Income	-9.56M
EBITDA	-9.49M
EBIT	-9.83M
Earnings Per Share (EPS)	-$8.04

Balance Sheet

The company has $4.83 million in cash and $724,848 in debt, giving a net cash position of $4.10 million or $1.59 per share.

Cash & Cash Equivalents	4.83M
Total Debt	724,848
Net Cash	4.10M
Net Cash Per Share	$1.59
Equity (Book Value)	4.33M
Book Value Per Share	2.48
Working Capital	3.19M

Cash Flow

In the last 12 months, operating cash flow was -$8.54 million and capital expenditures -$7,099, giving a free cash flow of -$8.55 million.

Operating Cash Flow	-8.54M
Capital Expenditures	-7,099
Free Cash Flow	-8.55M
FCF Per Share	-$3.31

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Aethlon Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-291.02%
Shareholder Yield	-291.02%
Earnings Yield	-186.02%
FCF Yield	-166.30%

Analyst Forecast

The average price target for Aethlon Medical is $7.00, which is 251.76% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	251.76%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 9, 2025. It was a reverse split with a ratio of 0.125:1.

Last Split Date	Jun 9, 2025
Split Type	Reverse
Split Ratio	0.125:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1